Patent Number: 6,514,966

Title: Compounds for the treatment of obesity

Abstract: NPY antagonists, methods of using such NPY antagonists and pharmaceutical compositions containing such NPY antagonists. The NPY antagonists are useful for the treatment of NPY mediated disease/conditions including obesity.

Inventors: Elliott; Richard L. (East Lyme, CT), Hank; Richard F. (No. Stonington, CT), Hammond; Marlys (Salem, CT)

Assignee: Pfizer Inc.

International Classification: C07D 401/00 (20060101); C07D 401/12 (20060101); C07D 401/04 (20060101); A61K 031/416 (); A61K 031/44 (); C07D 213/00 (); C07D 401/00 (); C07D 233/54 ()

Expiration Date: 02/04/2011